Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high ( MSI ‐H) molecular subtype

Molecular Oncology(2024)10.1002/1878-0261.13698Source: DataRank Database

ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high ( MSI ‐H) molecular subtype is a research paper published in Molecular Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.36)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Pier Selenica ORCID,Weining Ma ORCID,Sara Moufarrij,Christian Dagher ORCID,Thais Basili ORCID

Live enrichment

PubMed:39031567 PMC:PMC11459037 OpenAlex:https://openalex.org/W4400810123

NIH/NCI

Grant: P30CA008748 S5

NCI NIH HHS

Grant: P30 CA008748

Foundation of Women's Cancer Grant

Fonds de recherche du Québec - Santé

Cycle for Survival

Ovarian Cancer Research Alliance

Breast Cancer Research Foundation

Ovarian Cancer Research Alliance

Foundation of Women's Cancer Grant

Breast Cancer Research Foundation

Cycle for Survival

Fonds de recherche du Québec - Santé

FWCI

0.36

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13698

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13698

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13698

journalhttps://doi.org/10.1002/1878-0261.13698

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39031567

Fields of Study

HER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsEndometrial and Cervical Cancer TreatmentsHumansFemaleEndometrial NeoplasmsMicrosatellite InstabilityErb-b2 Receptor Tyrosine KinasesMutationMiddle AgedAgedAdultAged, 80 and over

MeSH Terms

AdultAgedAged, 80 and overFemaleHumansMiddle AgedMutationEndometrial NeoplasmsReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesMicrosatellite Instability

Keywords

Microsatellite instabilityBiologyCancer researchMutationMolecular biologyWild typeGeneticsMicrosatelliteGeneAlleleMutanterbB2Endometrial CancerHer2

Sustainable Development Goals

SDG 0: Good health and well-being

ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high ( MSI ‐H) molecular subtype

FAIR Checklist

Authors (13)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)